glp-1 brain inflammation Regulation of neuroinflammation with receptor targeting nanostructures to alleviate Alzheimer's symptoms in the disease models GLP-1 Benefits No One Tells

Medicaid integration begins in May 2026, bringing GLP-1 access to qualifying low-income populations

Clinical trials have demonstrated impressive weight reduction in individuals using Tirzepatide, making it a promising option for those seeking effective weight management solutions

10.1111/dom.14280 24

Guanosine prevents oxidative damage and glutamate uptake impairment induced by oxygen/glucose deprivation in cortical astrocyte cultures: involvement of A 1 and A 2A adenosine receptors and PI3K, MEK, and PKC pathways

The Cladophora glomerata enriched by biosorption process in Cr(III) improves viability, and reduces oxidative stress and apoptosis in Equine Metabolic Syndrome derived adipose mesenchymal stromal stem cells (ASCs) and their extracellular vesicles (MVs)

Dropout rates of 15% were found in several long-term trials (12 months), with higher attrition in GLP-1 RA groups, potentially due to gastrointestinal side effects